SCHEMBL192563

SCHEMBL192563

Cc1ncsc1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27963333 0.98 KDM4E (0.96)
Hydrochloric Acid SCHEMBL8624744 0.98 KDM4E (0.96)
Benzene SCHEMBL28205648 0.98 KDM4E (0.96)
Dimethylformamide SCHEMBL27620258 0.87 KDM4E (0.76)
SCHEMBL8682418 0.84 PKM (0.72)
SCHEMBL29015082 0.83 PKM (0.70)
SCHEMBL7962955 0.82
SCHEMBL5725392 0.82
SCHEMBL1667399 0.80
Furan-2(5H)-One SCHEMBL28436911 0.79 PKM (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 704 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111072591-B Febuxostat and intermediates and synthesis thereof 杭州朱养心药业有限公司 2025-03-28 CN claimed
CN-111039891-B Method for synthesizing febuxostat and intermediate thereof 杭州朱养心药业有限公司 2025-03-28 CN claimed
US-20250084074-A1 SUBSTITUTED HETEROCYCLES AS HSET INHIBITORS MERCK PATENT GMBH (DE) 2025-03-13 US claimed
CN-119528900-A Methylthiazole derivative with anti-liver cancer activity and preparation method and application thereof 河南科技大学 2025-02-28 CN claimed
CN-119504640-A Febuxostat preparation technology 哈药集团技术中心 2025-02-25 CN claimed
CN-118994140-A Triazole derivative with antidepressant effect, and preparation method and application thereof 河南科技大学 2024-11-22 CN claimed
CN-118994141-A Phenylthiazole derivative with anti-liver cancer and anti-inflammatory activities and preparation method and application thereof 河南科技大学 2024-11-22 CN claimed
CN-110167944-B Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors 联合疗法公司 2024-08-23 CN claimed
CN-118206505-A Near infrared fluorescent probe for identifying erythromycin and preparation method and application thereof 忻州师范学院 2024-06-18 CN claimed
CN-115772137-B Preparation method of febuxostat 济宁晟泰药业有限公司 2024-05-10 CN claimed
EP-1894568-A1 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases Novartis AG (CH) 2008-03-05 EP claimed
WO-2007136703-A1 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2007-11-29 WO claimed
CN-101020668-A Process of synthesizing 4-methyl-5-formyl thiazole UNIV TSINGHUA (CN) 2007-08-22 CN claimed
US-20070032478-A1 Kinase Inhibitors ALLERGAN, INC. 2007-02-08 US claimed
WO-2007008895-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2007-01-18 WO claimed
WO-2005100330-A1 PREPARATION OF INTERMEDIATE FOR 3-[2-(4-METHYLTHIAZOLE-5-YL)VINYL] CEPHALOSPORINS RANBAXY LABORATORIES LIMITED (IN) 2005-10-27 WO claimed
US-6255339-B1 PREVENTION PROSGESTERONE RECEPTOR BINDING MEIJI SEIKA KAISHA, LTD. (JP) 2001-07-03 US claimed
EP-0885893-A1 NOVEL TETRAHYDRONAPHTHOFURANONE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME MEIJI SEIKA KAISHA LTD. (JP) 1998-12-23 EP claimed
EP-0015824-B1 METAL DITHIOPHOSPHATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ADDITIVES FOR LUBRICATING OILS OROGIL (FR) 1982-02-17 EP claimed
US-4288335-A REACTING ESTER WITH PHOSPHORUS SULFIDE, METAL OXIDE OROGIL (FR) 1981-09-08 US claimed